Last reviewed · How we verify
NCT03884179
Diagnosis of PCL With EUS-FNA and Cross-sectional Imaging - A Report of Accuracy
trial in Pancreatic Cyst in 58 participants. Status unknown.
1 December 2017
Quick facts
| Lead sponsor | Sahlgrenska University Hospital |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 58 |
| Start date | 1 February 2007 |
| Primary completion | 1 December 2017 |
| Estimated completion | 1 March 2020 |
Conditions studied
- Pancreatic Cyst — all drugs for Pancreatic Cyst →
- Pancreatic Neuroendocrine Carcinoma — all drugs for Pancreatic Neuroendocrine Carcinoma →
- Pancreatic Pseudocyst — all drugs for Pancreatic Pseudocyst →
- Pancreatic Serous Cystadenoma — all drugs for Pancreatic Serous Cystadenoma →
Sponsor
Sahlgrenska University Hospital
Who can join
Eligibility, any sex, with Pancreatic Cyst or Pancreatic Neuroendocrine Carcinoma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Pancreatic cystic lesions (PCLs) comprise of a heterogeneous group of entities that are benign, premalignant or malignant. With increased use of modern imaging techniques in recent years, incidentally discovered PCL have become much more common. However, imaging modalities for characterising PCL is a known clinical uncertainty since imaging is capable of detecting these lesions but may often not be able to distinguish malignant from benign lesions. Incorrect assessment of PCL can lead to fatal consequences because a malignant lesion may not be treated and a benign may be unnecessarily resected. The aim of this study was to assess the performance of endoscopic ultrasound with fine-needle aspiration (EUS-FNA) in the diagnosis of pancreatic cystic lesions compared to cross-sectional imaging modalities (CT/MRI). Our hypothesis is that EUS-FNA has a higher accuracy for diagnosing PCLs compared with cross-sectional imaging.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
EUS is accurate in characterizing pancreatic cystic lesions; a prospective comparison with cross-sectional imaging in resected cases.
Wesali S, Demir MA, Verbeke CS, Andersson M, et al · · 2021 · cited 10× · PMID 33259018 · DOI 10.1007/s00464-020-08166-3
Verify or expand the search:
- PubMed search for NCT03884179
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pancreatic Cyst
Currently open trials in the same condition.
- NCT06939023 — Laparoscopic Versus Robot-assisted Left-sided Pancreatectomy for Benign and Pre-malignant Lesions (DIPLOMA-3) · NA · recruiting
- NCT06305728 — Hyperpolarized C Pyruvate Magnetic Resonance Imaging, and Blood-Based Biomarkers for Early Detection of Pancreatic Adeno · recruiting
- NCT05873699 — Study Using Hyperpolarized 13C-Pyruvate Magnetic Resonance Spectroscopic Imaging in Patients With Pancreatic Cysts Under · Phase 1 · recruiting
- NCT05334836 — Determination of Pancreatic Steatosis Prevalence and Correlation With High-risk Cyst Features · NA · recruiting
- NCT06706700 — Endocrine, Metabolic, Inflammatory Biomarkers to Identify Highgrade Dysplasia/invasive Carcinoma in Patients with IPMN o · recruiting
Other Sahlgrenska University Hospital trials
Trials by the same sponsor.
- NCT07491094 — Repeated Examinations for Typing Pulmonary Embolism · recruiting
- NCT07524608 — Implementing an Evidence-based, Standardized Care Bundle Targeting Register Nurses and Anaesthesiologists, to Enhance Pa · not yet recruiting
- NCT07498959 — Primary RPLND Versus Systemic Chemotherapy in Good-prognosis Metastatic Testicular Cancer · NA · recruiting
- NCT06896578 — Latitude - Lateral Lymph Node Attitude Study · NA · not yet recruiting
- NCT07035600 — Walking and Sitting Difficulties After Rectal Cancer Surgery · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03884179 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sahlgrenska University Hospital
- Last refreshed: 21 March 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03884179.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing